Citation Impact
Citing Papers
Medicine & science in sports & exercise
1994 Standout
The evolving epidemiology of valvular aortic stenosis. The Tromsø Study
2012
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Forecasting the Impact of Heart Failure in the United States
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1
2007 StandoutNobel
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
2017
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
The Generation R Study: design and cohort update 2010
2010 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
A global view of pulmonary hypertension
2016 Standout
Characterization of an ATP-sensitive K+ channel in rat carotid body glomus cells
2011
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
2018 Standout
The role of mitochondria in protection of the heart by preconditioning
2007
Transgenesis and cardiac energetics: new insights into cardiac metabolism
2004
Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study
2014
Multimodal biomedical AI
2022 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Myocarditis
2011 Standout
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors
2020
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
2017
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Atherosclerosis
2019 Standout
Gaseous messengers in oxygen sensing
2012 StandoutNobel
An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds
2017 Standout
NAFLD: A multisystem disease
2015 Standout
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
2018
Gut microbiota in human metabolic health and disease
2020 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Traffic-related Air Pollution and the Right Ventricle. The Multi-ethnic Study of Atherosclerosis
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Gene knockout of the KCNJ8‐encoded Kir6.1 K ATP channel imparts fatal susceptibility to endotoxemia
2006
The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease
2020
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score
2019
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Epidemiology of Heart Failure
2013
Caregivers’ contributions to heart failure self-care: A systematic review
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
2017
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
The Heart Failure Epidemic
2010
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
2019
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction
2014
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Biomarker definitions and their applications
2018 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Heart Disease Identification Method Using Machine Learning Classification in E-Healthcare
2020 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010
2015
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Christopher E. Kurtz being referenced
Use of Ejection Fraction Tests and Coronary Angiography in Patients With Heart Failure
2006
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
2017
KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart
2006
Aortic Stenosis
2010
Cognitive Function in a Randomized Trial of Evolocumab
2017
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease
2018
Design and rationale of the EBBINGHAUS trial: A phase 3, double‐blind, placebo‐controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid‐lowering therapy—A cognitive study of patients enrolled in the FOURIER trial
2017
Three‐Dimensional Analysis of Right Ventricular Shape and Function in Pulmonary Hypertension
2012
Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics
2003